164 related articles for article (PubMed ID: 35337131)
1. Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget Drugs.
von Bredow L; Schäfer TM; Hogenkamp J; Tretbar M; Stopper D; Kraft FB; Schliehe-Diecks J; Schöler A; Borkhardt A; Bhatia S; Held J; Hansen FK
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337131
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the in vitro and in vivo efficacy of peptoid-based HDAC inhibitors with dual-stage antiplasmodial activity.
Mackwitz MKW; Hesping E; Eribez K; Schöler A; Antonova-Koch Y; Held J; Winzeler EA; Andrews KT; Hansen FK
Eur J Med Chem; 2021 Feb; 211():113065. PubMed ID: 33360801
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of Thymoquinone-Artemisinin Hybrids: New Potent Antileukemia, Antiviral, and Antimalarial Agents.
Fröhlich T; Reiter C; Saeed MEM; Hutterer C; Hahn F; Leidenberger M; Friedrich O; Kappes B; Marschall M; Efferth T; Tsogoeva SB
ACS Med Chem Lett; 2018 Jun; 9(6):534-539. PubMed ID: 29937978
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of Novel Hybrids of Quinazoline and Artemisinin with High Activities against
Fröhlich T; Reiter C; Ibrahim MM; Beutel J; Hutterer C; Zeitträger I; Bahsi H; Leidenberger M; Friedrich O; Kappes B; Efferth T; Marschall M; Tsogoeva SB
ACS Omega; 2017 Jun; 2(6):2422-2431. PubMed ID: 30023664
[TBL] [Abstract][Full Text] [Related]
5. Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages.
Hansen FK; Sumanadasa SD; Stenzel K; Duffy S; Meister S; Marek L; Schmetter R; Kuna K; Hamacher A; Mordmüller B; Kassack MU; Winzeler EA; Avery VM; Andrews KT; Kurz T
Eur J Med Chem; 2014 Jul; 82():204-13. PubMed ID: 24904967
[TBL] [Abstract][Full Text] [Related]
6. Antiplasmodial dihetarylthioethers target the coenzyme A synthesis pathway in Plasmodium falciparum erythrocytic stages.
Weidner T; Lucantoni L; Nasereddin A; Preu L; Jones PG; Dzikowski R; Avery VM; Kunick C
Malar J; 2017 May; 16(1):192. PubMed ID: 28502250
[TBL] [Abstract][Full Text] [Related]
7. Hybrid Gold(I) NHC-Artemether Complexes to Target Falciparum Malaria Parasites.
Ouji M; Barnoin G; Fernández Álvarez Á; Augereau JM; Hemmert C; Benoit-Vical F; Gornitzka H
Molecules; 2020 Jun; 25(12):. PubMed ID: 32570872
[TBL] [Abstract][Full Text] [Related]
8. Design and Synthesis of Terephthalic Acid-Based Histone Deacetylase Inhibitors with Dual-Stage Anti-Plasmodium Activity.
Stenzel K; Chua MJ; Duffy S; Antonova-Koch Y; Meister S; Hamacher A; Kassack MU; Winzeler E; Avery VM; Kurz T; Andrews KT; Hansen FK
ChemMedChem; 2017 Oct; 12(19):1627-1636. PubMed ID: 28812327
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of quinoline-pyrimidine inspired hybrids as potential plasmodial inhibitors.
Kayamba F; Malimabe T; Ademola IK; Pooe OJ; Kushwaha ND; Mahlalela M; van Zyl RL; Gordon M; Mudau PT; Zininga T; Shonhai A; Nyamori VO; Karpoormath R
Eur J Med Chem; 2021 May; 217():113330. PubMed ID: 33744688
[TBL] [Abstract][Full Text] [Related]
10. Anti-plasmodial activity of Norcaesalpin D and extracts of four medicinal plants used traditionally for treatment of malaria.
Nondo RS; Moshi MJ; Erasto P; Masimba PJ; Machumi F; Kidukuli AW; Heydenreich M; Zofou D
BMC Complement Altern Med; 2017 Mar; 17(1):167. PubMed ID: 28340622
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, antimalarial properties, and SAR studies of alkoxyurea-based HDAC inhibitors.
Hansen FK; Skinner-Adams TS; Duffy S; Marek L; Sumanadasa SD; Kuna K; Held J; Avery VM; Andrews KT; Kurz T
ChemMedChem; 2014 Mar; 9(3):665-70. PubMed ID: 24497437
[TBL] [Abstract][Full Text] [Related]
12. QSAR Classification Models for Prediction of Hydroxamate Histone Deacetylase Inhibitor Activity against Malaria Parasites.
Hesping E; Chua MJ; Pflieger M; Qian Y; Dong L; Bachu P; Liu L; Kurz T; Fisher GM; Skinner-Adams TS; Reid RC; Fairlie DP; Andrews KT; Gorse AJP
ACS Infect Dis; 2022 Jan; 8(1):106-117. PubMed ID: 34985259
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium berghei K13 Mutations Mediate
Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
[TBL] [Abstract][Full Text] [Related]
14. Antimalarial activity of the anticancer histone deacetylase inhibitor SB939.
Sumanadasa SD; Goodman CD; Lucke AJ; Skinner-Adams T; Sahama I; Haque A; Do TA; McFadden GI; Fairlie DP; Andrews KT
Antimicrob Agents Chemother; 2012 Jul; 56(7):3849-56. PubMed ID: 22508312
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice.
Chua MJ; Tng J; Hesping E; Fisher GM; Goodman CD; Skinner-Adams T; Do D; Lucke AJ; Reid RC; Fairlie DP; Andrews KT
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():118-127. PubMed ID: 34560571
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of Novel Artemisinin, Ciprofloxacin, and Norfloxacin Hybrids with Potent Antiplasmodial Activity.
Vamvoukaki G; Antoniou AI; Baltas M; Mouray E; Charneau S; Grellier P; Athanassopoulos CM
Antibiotics (Basel); 2024 Feb; 13(2):. PubMed ID: 38391528
[TBL] [Abstract][Full Text] [Related]
17. Antiplasmodial activity of the natural product compounds alstonine and himbeline.
Arnold MSJ; Macdonald JR; Quinn RJ; Skinner-Adams TS; Andrews KT; Fisher GM
Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():17-22. PubMed ID: 33915339
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Antiplasmodial Activity of Hybrid Compounds Based on (2R,3S)-N-Benzoyl-3-phenylisoserine.
Njogu PM; Gut J; Rosenthal PJ; Chibale K
ACS Med Chem Lett; 2013 Jul; 4(7):637-41. PubMed ID: 24900723
[TBL] [Abstract][Full Text] [Related]
19. Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities.
Reiter C; Fröhlich T; Gruber L; Hutterer C; Marschall M; Voigtländer C; Friedrich O; Kappes B; Efferth T; Tsogoeva SB
Bioorg Med Chem; 2015 Sep; 23(17):5452-8. PubMed ID: 26260339
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Artemisinin-Estrogen Hybrids Highly Active against HCMV,
Fröhlich T; Kiss A; Wölfling J; Mernyák E; Kulmány ÁE; Minorics R; Zupkó I; Leidenberger M; Friedrich O; Kappes B; Hahn F; Marschall M; Schneider G; Tsogoeva SB
ACS Med Chem Lett; 2018 Nov; 9(11):1128-1133. PubMed ID: 30429957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
